Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uresta is a Canadian femtech and medical device company commercializing a reusable, over-the-counter bladder support device for women with stress urinary incontinence. Its core product, the Uresta bladder support starter kit, is a self-fit intravaginal pessary designed to support the bladder and help prevent leaks during activities such as coughing, laughing, sneezing, and exercise. The company positions Uresta as a non-surgical alternative to absorbent products and prescription-only interventions, and markets it directly to consumers as well as through healthcare professionals. The business appears focused on pelvic health and women’s continence care rather than therapeutics or drug development. Uresta has been active in Canada and expanded into the United States in 2025 following a reported $3 million financing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uresta.